NCT03411980 2019-12-03Pharmacokinetics and Safety of Vilaprisan in Renal ImpairmentBayerPhase 1 Completed26 enrolled
NCT03092999 2017-08-18Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)BayerPhase 1 Completed36 enrolled
NCT01816815 2014-04-21Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670BayerPhase 1 Completed73 enrolled